Correction: Sirtuin family in autoimmune diseases - Report - MDSpire

Correction: Sirtuin family in autoimmune diseases

  • By

  • Zhengjie Tao

  • Zihan Jin

  • Jiabiao Wu

  • Gaojun Cai

  • Xiaolong Yu

  • June 24, 2026

  • 0 min

Share

Correction: The Role of Sirtuins in Autoimmune Disorders

Background

Sirtuins are a family of proteins that play critical roles in cellular regulation, including immune responses and inflammation. Understanding their function in autoimmune disorders is essential. The correction highlights the importance of accurate terminology in clinical research, particularly in the context of treatment for conditions like multiple sclerosis.

Data Highlights

No numerical or trial data is presented in the correction article.

Key Findings

  • The term 'gramoxone acetate' was incorrectly used in the original article.
  • The correction specifies that glatiramer acetate is used in the treatment of multiple sclerosis.
  • Ciriello et al. studied PBMCs from multiple sclerosis patients treated with glatiramer acetate.
  • Related literature discusses the role of sirtuins in various autoimmune diseases.

Clinical Implications

Accurate terminology is crucial in clinical research to avoid confusion regarding treatment options.

Conclusion

The correction serves as a reminder of the importance of precision in medical literature.

Related Resources & Content

  1. Tao Z, Jin Z, Wu J, Cai G, Yu X, Front. Immunol., 2023 -- Sirtuin family in autoimmune diseases
  2. Frontiers in Immunology — The SIRT1/STAT3 axis as a central regulator of immune, inflammatory, and lipid metabolic dysregulation in rheumatoid arthritis: therapeutic implications
  3. Basic Research in Cardiology — The Promising Functions of Sirtuins in the Context of Heart Failure
  4. Frontiers in Immunology — Editorial: The role of innate immunity in the pathogenesis of autoimmune and autoinflammatory diseases
  5. Frontiers in Immunology — Mechanisms outpacing medicine in autoinflammatory diseases
  6. ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
  7. Tissue Immunometabolism in Autoimmunity - Villa - 2026 - European Journal of Immunology - Wiley Online Library
  8. Effects of resveratrol supplementation on inflammatory markers, fatigue scale, fasting blood sugar and lipid profile in relapsing-remitting multiple sclerosis patients: a double-blind, randomized placebo-controlled trial - PubMed

Original Source(s)

Related Content